Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Specimen Handling 79Fluorouracil 72Oxaliplatin 67Magnetic Resonance Spectroscopy 60Leucovorin 55Gemcitabine 51Bevacizumab 51Biopsy 40Capecitabine 39Cisplatin 36Nivolumab 34Irinotecan 34pembrolizumab 33Cetuximab 30durvalumab 29Paclitaxel 26130-nm albumin-bound paclitaxel 24atezolizumab 19Folfox protocol 19Radiotherapy 17Carboplatin 17dehydroftorafur 15Taxes 15X-Rays 13Radiation 13Cyclophosphamide 13trastuzumab deruxtecan 12Surgical Procedures, Operative 12fludarabine 11Immunoglobulin G 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholecalciferol × Gastrointestinal × 30 days × Clear all
NCT02172651 2026-05-13

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡